Clinical trial
Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids
NCT00156195 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00156195 |
|---|---|
| Title | Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids |
| Official title | A Phase 3, 12-Month, Extension Study to Evaluate the Safety of Asoprisnil in Subjects With Uterine Leiomyomata |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leiomyoma, Menorrhagia, Metrorrhagia |
| Intervention type | Drug |
| Interventions | Asoprisnil |
| Enrollment | 523 |
| Start date | Sep 1, 2003 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | May 29, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: